Lenalidomide and ILT2 blockade enhance NK cell function in chronic lymphocytic Leukemia
Publication date:
2019
Publisher version:
Descripción física:
p. 1766-1767
Description:
International Congress of Immunology (IUIS) (17th. 2019. Beijing, China)